These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 24682267)

  • 1. The genomic landscape of mantle cell lymphoma is related to the epigenetically determined chromatin state of normal B cells.
    Zhang J; Jima D; Moffitt AB; Liu Q; Czader M; Hsi ED; Fedoriw Y; Dunphy CH; Richards KL; Gill JI; Sun Z; Love C; Scotland P; Lock E; Levy S; Hsu DS; Dunson D; Dave SS
    Blood; 2014 May; 123(19):2988-96. PubMed ID: 24682267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Landscape of somatic mutations and clonal evolution in mantle cell lymphoma.
    Beà S; Valdés-Mas R; Navarro A; Salaverria I; Martín-Garcia D; Jares P; Giné E; Pinyol M; Royo C; Nadeu F; Conde L; Juan M; Clot G; Vizán P; Di Croce L; Puente DA; López-Guerra M; Moros A; Roue G; Aymerich M; Villamor N; Colomo L; Martínez A; Valera A; Martín-Subero JI; Amador V; Hernández L; Rozman M; Enjuanes A; Forcada P; Muntañola A; Hartmann EM; Calasanz MJ; Rosenwald A; Ott G; Hernández-Rivas JM; Klapper W; Siebert R; Wiestner A; Wilson WH; Colomer D; López-Guillermo A; López-Otín C; Puente XS; Campo E
    Proc Natl Acad Sci U S A; 2013 Nov; 110(45):18250-5. PubMed ID: 24145436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene mutations and actionable genetic lesions in mantle cell lymphoma.
    Ahmed M; Zhang L; Nomie K; Lam L; Wang M
    Oncotarget; 2016 Sep; 7(36):58638-58648. PubMed ID: 27449094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subclonal evolution of a classical Hodgkin lymphoma from a germinal center B-cell-derived mantle cell lymphoma.
    Schneider S; Crescenzi B; Schneider M; Ascani S; Hartmann S; Hansmann ML; Falini B; Mecucci C; Tiacci E; Küppers R
    Int J Cancer; 2014 Feb; 134(4):832-43. PubMed ID: 23929122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early B-cell-specific inactivation of ATM synergizes with ectopic CyclinD1 expression to promote pre-germinal center B-cell lymphomas in mice.
    Yamamoto K; Lee BJ; Li C; Dubois RL; Hobeika E; Bhagat G; Zha S
    Leukemia; 2015 Jun; 29(6):1414-24. PubMed ID: 25676421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic and epigenomic insights into the origin, pathogenesis, and clinical behavior of mantle cell lymphoma subtypes.
    Nadeu F; Martin-Garcia D; Clot G; Díaz-Navarro A; Duran-Ferrer M; Navarro A; Vilarrasa-Blasi R; Kulis M; Royo R; Gutiérrez-Abril J; Valdés-Mas R; López C; Chapaprieta V; Puiggros M; Castellano G; Costa D; Aymerich M; Jares P; Espinet B; Muntañola A; Ribera-Cortada I; Siebert R; Colomer D; Torrents D; Gine E; López-Guillermo A; Küppers R; Martin-Subero JI; Puente XS; Beà S; Campo E
    Blood; 2020 Sep; 136(12):1419-1432. PubMed ID: 32584970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations.
    Pugh TJ; Weeraratne SD; Archer TC; Pomeranz Krummel DA; Auclair D; Bochicchio J; Carneiro MO; Carter SL; Cibulskis K; Erlich RL; Greulich H; Lawrence MS; Lennon NJ; McKenna A; Meldrim J; Ramos AH; Ross MG; Russ C; Shefler E; Sivachenko A; Sogoloff B; Stojanov P; Tamayo P; Mesirov JP; Amani V; Teider N; Sengupta S; Francois JP; Northcott PA; Taylor MD; Yu F; Crabtree GR; Kautzman AG; Gabriel SB; Getz G; Jäger N; Jones DT; Lichter P; Pfister SM; Roberts TM; Meyerson M; Pomeroy SL; Cho YJ
    Nature; 2012 Aug; 488(7409):106-10. PubMed ID: 22820256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation and genomic deletion status of ataxia telangiectasia mutated (ATM) and p53 confer specific gene expression profiles in mantle cell lymphoma.
    Greiner TC; Dasgupta C; Ho VV; Weisenburger DD; Smith LM; Lynch JC; Vose JM; Fu K; Armitage JO; Braziel RM; Campo E; Delabie J; Gascoyne RD; Jaffe ES; Muller-Hermelink HK; Ott G; Rosenwald A; Staudt LM; Im MY; Karaman MW; Pike BL; Chan WC; Hacia JG
    Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2352-7. PubMed ID: 16461462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased proteasome degradation of cyclin-dependent kinase inhibitor p27 is associated with a decreased overall survival in mantle cell lymphoma.
    Chiarle R; Budel LM; Skolnik J; Frizzera G; Chilosi M; Corato A; Pizzolo G; Magidson J; Montagnoli A; Pagano M; Maes B; De Wolf-Peeters C; Inghirami G
    Blood; 2000 Jan; 95(2):619-26. PubMed ID: 10627471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ATM and TP53 mutations show mutual exclusivity but distinct clinical impact in mantle cell lymphoma patients.
    Mareckova A; Malcikova J; Tom N; Pal K; Radova L; Salek D; Janikova A; Moulis M; Smardova J; Kren L; Mayer J; Trbusek M
    Leuk Lymphoma; 2019 Jun; 60(6):1420-1428. PubMed ID: 30626249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The genetic landscape of mutations in Burkitt lymphoma.
    Love C; Sun Z; Jima D; Li G; Zhang J; Miles R; Richards KL; Dunphy CH; Choi WW; Srivastava G; Lugar PL; Rizzieri DA; Lagoo AS; Bernal-Mizrachi L; Mann KP; Flowers CR; Naresh KN; Evens AM; Chadburn A; Gordon LI; Czader MB; Gill JI; Hsi ED; Greenough A; Moffitt AB; McKinney M; Banerjee A; Grubor V; Levy S; Dunson DB; Dave SS
    Nat Genet; 2012 Dec; 44(12):1321-5. PubMed ID: 23143597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High level of cannabinoid receptor 1, absence of regulator of G protein signalling 13 and differential expression of Cyclin D1 in mantle cell lymphoma.
    Islam TC; Asplund AC; Lindvall JM; Nygren L; Liden J; Kimby E; Christensson B; Smith CI; Sander B
    Leukemia; 2003 Sep; 17(9):1880-90. PubMed ID: 12970790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The E3 ubiquitin ligase UBR5 is recurrently mutated in mantle cell lymphoma.
    Meissner B; Kridel R; Lim RS; Rogic S; Tse K; Scott DW; Moore R; Mungall AJ; Marra MA; Connors JM; Steidl C; Gascoyne RD
    Blood; 2013 Apr; 121(16):3161-4. PubMed ID: 23407552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone H1 loss drives lymphoma by disrupting 3D chromatin architecture.
    Yusufova N; Kloetgen A; Teater M; Osunsade A; Camarillo JM; Chin CR; Doane AS; Venters BJ; Portillo-Ledesma S; Conway J; Phillip JM; Elemento O; Scott DW; Béguelin W; Licht JD; Kelleher NL; Staudt LM; Skoultchi AI; Keogh MC; Apostolou E; Mason CE; Imielinski M; Schlick T; David Y; Tsirigos A; Allis CD; Soshnev AA; Cesarman E; Melnick AM
    Nature; 2021 Jan; 589(7841):299-305. PubMed ID: 33299181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aggressive morphologic variants of mantle cell lymphoma characterized with high genomic instability showing frequent chromothripsis, CDKN2A/B loss, and TP53 mutations: A multi-institutional study.
    Streich L; Sukhanova M; Lu X; Chen YH; Venkataraman G; Mathews S; Zhang S; Kelemen K; Segal J; Gao J; Gordon L; Chen Q; Behdad A
    Genes Chromosomes Cancer; 2020 Aug; 59(8):484-494. PubMed ID: 32277542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oligonucleotide microarrays demonstrate the highest frequency of ATM mutations in the mantle cell subtype of lymphoma.
    Fang NY; Greiner TC; Weisenburger DD; Chan WC; Vose JM; Smith LM; Armitage JO; Mayer RA; Pike BL; Collins FS; Hacia JG
    Proc Natl Acad Sci U S A; 2003 Apr; 100(9):5372-7. PubMed ID: 12697903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular characterization of sorted malignant B cells from patients clinically identified with mantle cell lymphoma.
    Hansen MH; Cédile O; Blum MK; Hansen SV; Ebbesen LH; Bentzen HHN; Thomassen M; Kruse TA; Kavan S; Kjeldsen E; Kristensen TK; Haaber J; Abildgaard N; Nyvold CG
    Exp Hematol; 2020 Apr; 84():7-18.e12. PubMed ID: 32173361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The many layers of epigenetic dysfunction in B-cell lymphomas.
    Jiang Y; Dominguez PM; Melnick AM
    Curr Opin Hematol; 2016 Jul; 23(4):377-84. PubMed ID: 27055146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma.
    Schwartzentruber J; Korshunov A; Liu XY; Jones DT; Pfaff E; Jacob K; Sturm D; Fontebasso AM; Quang DA; Tönjes M; Hovestadt V; Albrecht S; Kool M; Nantel A; Konermann C; Lindroth A; Jäger N; Rausch T; Ryzhova M; Korbel JO; Hielscher T; Hauser P; Garami M; Klekner A; Bognar L; Ebinger M; Schuhmann MU; Scheurlen W; Pekrun A; Frühwald MC; Roggendorf W; Kramm C; Dürken M; Atkinson J; Lepage P; Montpetit A; Zakrzewska M; Zakrzewski K; Liberski PP; Dong Z; Siegel P; Kulozik AE; Zapatka M; Guha A; Malkin D; Felsberg J; Reifenberger G; von Deimling A; Ichimura K; Collins VP; Witt H; Milde T; Witt O; Zhang C; Castelo-Branco P; Lichter P; Faury D; Tabori U; Plass C; Majewski J; Pfister SM; Jabado N
    Nature; 2012 Jan; 482(7384):226-31. PubMed ID: 22286061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic landscape and prognostic analysis of mantle cell lymphoma.
    Yang P; Zhang W; Wang J; Liu Y; An R; Jing H
    Cancer Gene Ther; 2018 Jun; 25(5-6):129-140. PubMed ID: 29755111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.